Last reviewed · How we verify

Botulinum Toxin Type A Injection [Botox]

Hugel · FDA-approved active Small molecule Quality 0/100

Botulinum Toxin Type A Injection [Botox] is a Small molecule drug developed by Hugel. It is currently FDA-approved. Also known as: Botox®, follow.

At a glance

Generic nameBotulinum Toxin Type A Injection [Botox]
Also known asBotox®, follow
SponsorHugel
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Botulinum Toxin Type A Injection [Botox]

What is Botulinum Toxin Type A Injection [Botox]?

Botulinum Toxin Type A Injection [Botox] is a Small molecule drug developed by Hugel.

Who makes Botulinum Toxin Type A Injection [Botox]?

Botulinum Toxin Type A Injection [Botox] is developed and marketed by Hugel (see full Hugel pipeline at /company/hugel).

Is Botulinum Toxin Type A Injection [Botox] also known as anything else?

Botulinum Toxin Type A Injection [Botox] is also known as Botox®, follow.

What development phase is Botulinum Toxin Type A Injection [Botox] in?

Botulinum Toxin Type A Injection [Botox] is FDA-approved (marketed).

Related